Table 7.
Stability analysis of the predictive models built from the set of 104 tetrabenazine and lobeline analogs
| NN11-3-1 model
|
|||
|---|---|---|---|
| No. | Train r2 (rmsd) | LOO q2 (rmsd) | Test r2 (rmsd) |
| 1 | 0.91 (0.225) | 0.82 (0.316) | 0.93 (0.282) |
| 2 | 0.93 (0.207) | 0.83 (0.330) | 0.89 (0.341) |
| 3 | 0.93 (0.220) | 0.81 (0.358) | 0.92 (0.303) |
| 4 | 0.92 (0.235) | 0.84 (0.339) | 0.88 (0.353) |
| 5 | 0.93 (0.223) | 0.80 (0.370) | 0.94 (0.246) |
|
| |||
| Avg. | 0.92 (0.222) | 0.82 (0.343) | 0.91 (0.305) |
| PLS model
|
|||
| No. | Train r2 (rmsd) | LOO q2 (rmsd) | Test r2 (rmsd) |
|
| |||
| 1 | 0.83 (0.303) | 0.78 (0.352) | 0.87 (0.415) |
| 2 | 0.84 (0.319) | 0.79 (0.373) | 0.86 (0.380) |
| 3 | 0.83 (0.330) | 0.78 (0.388) | 0.91 (0.301) |
| 4 | 0.85 (0.338) | 0.80 (0.379) | 0.86 (0.330) |
| 5 | 0.85 (0.320) | 0.80 (0.373) | 0.83 (0.403) |
|
| |||
| Avg. | 0.84 (0.322) | 0.79 (0.373) | 0.87 (0.366) |